Skip to main content
Cellromax Science Co., Ltd. logo

Cellromax Science Co., Ltd. — Investor Relations & Filings

Ticker · 471820 ISIN · KR7471820001 KO Manufacturing
Open in API
Filings indexed 90 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 471820

About Cellromax Science Co., Ltd.

https://www.cellromax.kr/

Cellromax Science Co., Ltd. is a company specializing in the research, development, and manufacturing of health-related products. Its portfolio is centered on three key areas: health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company leverages scientific research and high-quality, naturally derived ingredients to create unique and effective products. Its development philosophy emphasizes optimized formulas and specialized prescriptions designed to support consumer health, skin vitality, and overall well-being.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제13기) 2026년 01월 01일–2026년 03월 31일” and contains detailed interim/quarterly financial statements, management discussion, schedules of subsidiary information, capital changes, and other substantive financial data for the 1st quarter of fiscal 2026. It is clearly a quarterly (interim) report, not merely an announcement or presentation. Therefore, it should be classified as an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
현금ㆍ현물배당결정 (분기배당)
Notice of Dividend Amount Classification · 92% confidence The document is a corporate announcement of a cash/dividend distribution decision, detailing the per-share dividend amount, record date, payment date, total dividend, and board approval date. This matches the “Notice of Dividend Amount” category.
2026-04-20 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 95% confidence The document is a regulatory filing titled “주요사항보고서(자기주식취득 신탁계약 체결 결정),” detailing the decision to enter into a trust agreement for acquiring the company’s own shares (treasury stock). It includes contract amounts, dates, share quantities before and after acquisition, and related board resolution information. This matches the “Transaction in Own Shares” category, which covers reports of a company buying back or selling its own shares.
2026-04-20 Korean
[기재정정]현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 95% confidence The document is a formal corporate announcement detailing the company’s cash dividend decision, including per-share amount, total dividend, record date, payment date, approval body, and related notes. This matches the definition of a Notice of Dividend Amount (code DIV).
2026-04-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 85% confidence The document is a Korean ‘주식등의 대량보유상황보고서(일반)’ – a regulatory filing under the Capital Markets Act disclosing large shareholding positions and changes, including detailed tables of holdings, ownership percentages, change reasons (RSU grants), and related parties. This matches the definition of a Major Shareholding Notification (changes in significant share ownership levels).
2026-04-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a statutory insider ownership report (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive detailing changes in their holdings of the company’s shares. This aligns with our “Director’s Dealing” category, which covers insider share transactions by directors and executives.
2026-04-06 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.